Global Health Technology and Innovation
Global Health Technology and Innovation in the Health Systems Program
Our work in technology and innovation emphasizes the development and implementation of new technologies for greater health care access and impact, as well as ensuring that appropriate policies are in place to govern such technologies.
Our faculty work to ensure equitable access to innovative health technologies, from effective antibiotics and medicines to real-time surveillance of chronic and infectious diseases. The Program uses digital technologies to strengthen surveillance of noncommunicable disease risk factors and COVID-19 in low- and middle-income country settings.
Examples of Latest Projects
Innovation+Design Enabling Access (IDEA) Initiative: The IDEA Initiative seeks to reengineer how innovation and design of technologies better meet the health of those in need. From antimicrobial resistance to COVID-19, the Initiative works to support an end-to-end approach and shape an enabling environment, innovative financing, and product development partnership responsive to these needs.
Data for Health Initiative: The Data4Health Initiative supports national implementation of mobile phone surveys to collect noncommunicable disease risk factor information through the research and development of survey methodologies, costing analyses, and exploration of key ethical, legal, and societal issues.
Researchers Validate and Improve the Ability of Mobile Health Applications to Predict Mortality in the U.S. Population
BSPH News | June 2022
A new study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health found that an improved C-Score can identify 87% of individuals living in the United States who will experience premature mortality, or dying before the average life expectancy.
The Global Action Plan on Antimicrobial Resistance at a Crossroads: Insights from the WHO’s Comprehensive Review
IDEA Initiative | January 2022
The IDEA Initiative at Johns Hopkins, along with the ReAct – Action on Antibiotic Resistance Strategic Policy Program, has released a policy briefing in advance of the World Health Organization's 150th Executive Board Meeting. The briefing highlights eight key topics that need to be considered carefully for tackling antimicrobial resistance.
Professor Anthony So Appointed to the World Health Organization’s COVID-19 Technology Access Pool Technical Advisory Group (C-TAP)
World Health Organization | October 2021
C-TAP aims to make COVID-19 health technologies available and affordable for all countries. This group will advise the WHO on proposed or signed agreements and identify priority health products.
Meet our global health technology and innovation faculty
Joseph Ali, JD, studies how to conduct global public health research and practice that maximally respects ethical values in an increasingly interconnected digital world.
Dustin Gibson, PhD ’14, MS, develops and evaluates digital tools and technologies to address health system gaps in low- and middle-income countries
Anthony D. So, MD, MPA, works on research and policy to improve innovation and access to health technologies with a particular focus on antimicrobial resistance.
Andres Vecino, MD, PhD '16, MSc, uses economics theory and methods to improve health systems in lower and middle-income countries with a focus on Latin America.
Featured Publications and Reports
Civil Society Consultation on the FAO’s Global Campaign to Reduce the Need for Antimicrobials in Agri-Food Systems and the Antimicrobial Resistance (AMR) Multi-Stakeholder Partnership Platform
A novel score for mHealth apps to predict and prevent mortality: Further validation and adaptation to the U.S. population using the U.S. National Health and Nutrition Examination Survey Data Set
Journal of Medical Internet Research | June 2022
Aligning Incentives for Pharmaceutical Innovation to Achieve Fair Pricing
World Health Organization Fair Pricing Forum 2021 Discussion Paper | November 2021